Novavax (NVAX) Non-Current Assets (2016 - 2025)
Novavax (NVAX) has 16 years of Non-Current Assets data on record, last reported at $205.3 million in Q3 2025.
- For Q3 2025, Non-Current Assets fell 66.28% year-over-year to $205.3 million; the TTM value through Sep 2025 reached $1.5 billion, down 40.95%, while the annual FY2024 figure was $431.5 million, 33.98% down from the prior year.
- Non-Current Assets reached $205.3 million in Q3 2025 per NVAX's latest filing, down from $417.0 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $653.6 million in Q4 2023 and bottomed at $205.3 million in Q3 2025.
- Average Non-Current Assets over 5 years is $493.1 million, with a median of $487.5 million recorded in 2022.
- Peak YoY movement for Non-Current Assets: soared 396.43% in 2021, then tumbled 66.28% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $421.6 million in 2021, then skyrocketed by 31.7% to $555.3 million in 2022, then grew by 17.71% to $653.6 million in 2023, then crashed by 33.98% to $431.5 million in 2024, then crashed by 52.42% to $205.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Non-Current Assets were $205.3 million in Q3 2025, $417.0 million in Q2 2025, and $425.0 million in Q1 2025.